Literature DB >> 24203854

Update on pediatric opsoclonus myoclonus syndrome.

Barbara Hero1, Gudrun Schleiermacher.   

Abstract

Opsoclonus myoclonus syndrome (dancing eye syndrome) is a rare paraneoplastic syndrome characterized by opsoclonus, myoclonus, and ataxia, usually accompanied by behavioral abnormalities. In adults, opsoclonus myoclonus syndrome has been reported in association with different types of cancer; whereas in children, the syndrome may be associated with neuroblastic tumors. Although a direct proof is lacking, the syndrome is assumed to be of autoimmune origin. The treatment is corticosteroid based with the addition of other immunosuppressive or immunomodulating drugs if intensification seems necessary. Because of the rarity of the disease, international collaborations as well on research as on therapeutic strategies are urgently needed. A European consortium just started a trial for this rare condition. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24203854     DOI: 10.1055/s-0033-1358604

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

Review 1.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

Review 2.  Neuroblastoma: clinical and biological approach to risk stratification and treatment.

Authors:  Vanessa P Tolbert; Katherine K Matthay
Journal:  Cell Tissue Res       Date:  2018-03-23       Impact factor: 5.249

3.  Pediatric anti-NMDA receptor encephalitis is seasonal.

Authors:  Laura A Adang; David R Lynch; Jessica A Panzer
Journal:  Ann Clin Transl Neurol       Date:  2014-10-30       Impact factor: 4.511

4.  Anesthesia in a child with Kinsbourne syndrome: Does anesthesia technique matters?

Authors:  N Nisa; P Talawar; B Vasudevan
Journal:  Saudi J Anaesth       Date:  2016 Oct-Dec

5.  CRB1-associated retinal dystrophy presenting as self-resolving opsoclonus and posterior uveitis.

Authors:  Angela S Li; Malini Veerappan Pasricha; Kapil Mishra; Quan D Nguyen; Shannon J Beres; Edward H Wood
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.